期刊
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
卷 58, 期 1, 页码 1-14出版社
HUMANA PRESS INC
DOI: 10.1007/s12016-018-8714-z
关键词
Rheumatoid arthritis; Atherosclerosis; Neutrophil extracellular traps; Microbiome; Single nucleotide polymorphisms; Adipocytokines
资金
- European Commission [FP7-INNOVATION I HEALTH-F2-2013-602114]
- Italian Ministry of Health
- Fondazione CARIGE
Substantial epidemiological data identified cardiovascular (CV) diseases as a main cause of mortality in patients with rheumatoid arthritis (RA). In light of this, RA patients may benefit from additional CV risk screening and more intensive prevention strategies. Nevertheless, current algorithms for CV risk stratification still remain tailored on general population and are burdened by a significant underestimation of CV risk in RA patients. Acute CV events in patients with RA are largely related to an accelerated atherosclerosis. As pathophysiological features of atherosclerosis overlap those occurring in the inflamed RA synovium, the understanding of those common pathways represents an urgent need and a leading challenge for CV prevention in patients with RA. Genetic background, metabolic status, gut microbiome, and systemic inflammation have been also suggested as additional key pro-atherosclerotic factors. The aim of this narrative review is to update the current knowledge about pathophysiology of atherogenesis in RA patients and potential anti-atherosclerotic effects of disease-modifying anti-rheumatic drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据